180 Life Sciences Beta
Quel est le Beta de 180 Life Sciences?
Le Beta de 180 Life Sciences Corp. est 0.35
Quelle est la définition de Beta?
BETA indique si une action est plus ou moins volatile que le marché dans son ensemble. Un bêta inférieur à 1 indique que l'action est moins volatile que le marché, tandis qu'un bêta supérieur à 1 indique que l'action est plus volatile. La volatilité est mesurée par la fluctuation du prix autour de la moyenne.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta des entreprises dans Health Care secteur sur NASDAQ par rapport à 180 Life Sciences
Que fait 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Entreprises avec beta similaire à 180 Life Sciences
- Goldlion a Beta de 0.35
- AEON Credit Service (Asia) a Beta de 0.35
- Invitrocue a Beta de 0.35
- Marsh & McLennan Cos a Beta de 0.35
- Enzo Biochem a Beta de 0.35
- North European Oil Royalty Trust a Beta de 0.35
- 180 Life Sciences a Beta de 0.35
- Huanxi Media a Beta de 0.35
- China ITS () Co a Beta de 0.35
- United Utilities Plc a Beta de 0.35
- Ameriserv Inc a Beta de 0.35
- American Equity Investment Life Co a Beta de 0.35
- Peoples Bancorp Of North Carolina Inc a Beta de 0.35